$EXEL's fat wallet beefs up its cancer drug pipeline
Exelixis Inc. President and CEOwarned that the company wasn't going to just sit on its cancer drug franchise, not with $2 billion in cash, equivalents and investments.
In the Sairopa deal, Exelixis will pay $40 million upfront and $70 million in near-term milestones for an exclusive, worldwide license to develop and sell Sairopa's ADU-1805. The drug is a monoclonal antibody targeting a protein — called signal regulatory protein alpha, or SIRPa — that protects cancer-associated proteins from being detected by the immune system's T cells and helps block the ability to clear tumor cells.
The moves were announced as Exelixis reported its third-quarter financials that showed the company with a $212.4 million profit through the first nine months of the year on revenue of nearly $1.19 billion.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Puma CEO Gulden set to become new Adidas CEO - sourcePuma Chief Executive Bjorn Gulden is leaving the German sportswear maker at the end of the year to take the helm at rival Adidas , according to an industry source.
Weiterlesen »
An inside look into multi-family housing and the real estate market today - CEO SpotlightShakti C'Ganti, CEO, Ashland Greene Capital joins KRLD's David Johnson for this episode of CEO Spotlight.
Weiterlesen »
Exelixis puts fat wallet to work with Cybrexa, Sairopa deals - San Francisco Business TimesPresident and CEO Michael Morrissey said the deals tap the company's balance sheet and share risks with its partners.
Weiterlesen »
Boeing execs try to calm investors after multi-billion dollar lossBoeing President and CEO Dave Calhoun stressed that safety now dominates Boeing’s efforts.
Weiterlesen »
Crypto Winter Only Getting Worse but There's a Positive: Tezos CEOBreitman thinks the bear market will remain a challenge in the foreseeable future but useful crypto applications will flourish upon its end.
Weiterlesen »
Ryan Rogers, grandson of Mary Kay Ash, appointed to CEO of cosmetic company - Dallas Business JournalRyan Rogers is following in the footsteps of his grandmother and company founder Mary Kay Ash and father Richard R. Rogers.
Weiterlesen »